Valion Bio, Inc. Shares Outstanding
Valion Bio, Inc. (VBIO) had Shares Outstanding of 4.15 million shares as of 2026-06-30, per its 10-Q filed 2026-08-14.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-14
- 2026-06-30: Shares outstanding (split-adjusted) 4.15M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 2.88M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 2.53M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 1.66M shares; Shares authorized (split-adjusted) 200.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 4.15M shares 10-Q · filed 2026-08-14 | 200.00M shares 10-Q · filed 2026-08-14 |
| 2026-03-31 | 2.88M shares 10-Q · filed 2026-05-14 | 200.00M shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 2.53M shares 10-Q · filed 2026-08-14 | 200.00M shares 10-Q · filed 2026-08-14 |
| 2025-09-30 | 1.66M shares 10-Q · filed 2025-11-14 | 200.00M shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 965.90K shares 10-Q · filed 2025-08-14 | 200.00M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 705.64K shares 10-Q · filed 2025-05-15 | 200.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 556.90K shares 10-K · filed 2026-03-30 | 200.00M shares 10-K · filed 2026-03-30 |
| 2024-09-30 | 6.24M shares 10-Q · filed 2024-11-14 | 200.00M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 6.18M shares 10-Q · filed 2024-08-14 | 200.00M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 1.47M shares 10-Q · filed 2024-05-15 | 200.00M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 86.24K shares 10-K · filed 2025-03-21 | 200.00M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 1.47M shares 10-Q · filed 2023-11-14 | 200.00M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 29.68M shares 10-Q · filed 2023-08-14 | 200.00M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 29.68M shares 10-Q · filed 2023-05-15 | 200.00M shares 10-Q · filed 2023-05-15 |
| 2022-12-31 | 96.78K shares 10-K · filed 2024-03-25 | 200.00M shares 10-K · filed 2024-03-25 |
| 2022-09-30 | 9.68M shares 10-Q · filed 2022-11-14 | 200.00M shares 10-Q · filed 2022-11-14 |
| 2022-06-30 | 9.62M shares 10-Q · filed 2022-08-15 | 200.00M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 9.72M shares 10-Q · filed 2022-05-16 | 200.00M shares 10-Q · filed 2022-05-16 |
| 2021-12-31 | 9.72M shares 10-K · filed 2023-03-31 | 200.00M shares 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |